SUBSCRIBE
SUBSCRIBE

TG Therapeutics, Inc.

NEWS
Pharm Country
TG Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare ConferencePresentation scheduled for Tuesday, January 12, 2021 at 2:00 PM ET
January 8, 2021
 · 
1 min read
BioMidwest
Biopharma Money on the Move: December 16-22
December 23, 2020
 · 
4 min read
 · 
Kate Goodwin
Deals
TG Therapeutics Announces Pricing of Upsized Public Offering of Common Stock - Dec 15, 2020
December 14, 2020
 · 
5 min read
Pharm Country
TG Therapeutics Announces Proposed Public Offering of Common Stock
December 14, 2020
 · 
5 min read
Ublituximab shows better results than Aubagio in p
Drug Development
TG’s New Drug Ublituximab Outshines Sanofi’s Aubagio in MS Phase III Trial
December 10, 2020
 · 
3 min read
 · 
Mark Terry
Drug Development
TG Therapeutics Announces Positive Topline Results from the ULTIMATE I & II Phase 3 Studies Evaluating Ublituximab Monotherapy for the Treatment of Patients with Multiple Sclerosis
December 10, 2020
 · 
8 min read
Pharm Country
TG Therapeutics Announces Pivotal Data from the UNITY-CLL and UNITY-NHL Clinical Trials Presented at the 62nd American Society of Hematology Annual Meeting
December 7, 2020
 · 
9 min read
Pharm Country
TG Therapeutics Announces Triple Combination Data Presentations at the at the 62nd American Society of Hematology Annual Meeting
December 7, 2020
 · 
7 min read
Drug Development
Clinical Catch-Up: November 30-December 4
December 4, 2020
 · 
8 min read
 · 
Mark Terry
Pharm Country
TG Therapeutics Recaps Schedule of Data Presentations at the Upcoming 62nd American Society of Hematology Annual Meeting and Exposition
December 3, 2020
 · 
5 min read
Drug Development
TG Therapeutics Announces Publication of Phase 2 Data Evaluating Umbralisib in Patients with Chronic Lymphocytic Leukemia Who Are Intolerant to Prior BTK or PI3K Inhibitor Therapy in Blood
December 2, 2020
 · 
5 min read
Pharm Country
TG Therapeutics Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration for Ublituximab in Combination with Umbralisib as a Treatment for Patients with Chronic Lymphocytic Leukemia
December 1, 2020
 · 
8 min read
Pharm Country
TG Therapeutics to Participate in the 3rd Annual Evercore ISI HealthCONx ConferenceFireside chat scheduled for Tuesday, December 1, 2020 at 10:05 AM ET
November 30, 2020
 · 
1 min read
Pharm Country
TG Therapeutics to Participate in the Jefferies Virtual London Healthcare ConferenceFireside chat scheduled for Tuesday, November 17, 2020 at 2:20 PM ET/ 7:20 PM GMT
November 13, 2020
 · 
1 min read
Business
TG Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results
November 9, 2020
 · 
11 min read
Pharm Country
TG Therapeutics Highlights Data Selected for Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting
November 4, 2020
 · 
10 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
JOBS